Eric Raymond

528 total citations
8 papers, 387 citations indexed

About

Eric Raymond is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Eric Raymond has authored 8 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Organic Chemistry. Recurrent topics in Eric Raymond's work include Cancer Treatment and Pharmacology (5 papers), Prostate Cancer Treatment and Research (2 papers) and PARP inhibition in cancer therapy (2 papers). Eric Raymond is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Prostate Cancer Treatment and Research (2 papers) and PARP inhibition in cancer therapy (2 papers). Eric Raymond collaborates with scholars based in France, Switzerland and United States. Eric Raymond's co-authors include Sandrine Faivre, Jean Pierre Armand, Henri Bismuth, V. Tricottet, M Reynès, Didier Samuel, Tu Nguyen‐Ngoc, Christophe Louvet, A M Coudray and Christian Gespach and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Drugs.

In The Last Decade

Eric Raymond

8 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Raymond France	4	229	152	132	58	41	8	387
Maura Loprevite Italy	11	207 0.9×	177 1.2×	184 1.4×	36 0.6×	21 0.5×	20	366
Hiroto Kishi Japan	10	245 1.1×	208 1.4×	145 1.1×	34 0.6×	34 0.8×	21	435
Akio Fujioka Japan	13	362 1.6×	206 1.4×	122 0.9×	46 0.8×	20 0.5×	21	518
Maria S. Romero Spain	5	297 1.3×	235 1.5×	266 2.0×	30 0.5×	48 1.2×	6	497
F. Eskens Netherlands	10	244 1.1×	153 1.0×	189 1.4×	29 0.5×	26 0.6×	20	366
Kishore Shakalya United States	4	120 0.5×	204 1.3×	85 0.6×	20 0.3×	30 0.7×	6	423
I. Judson United Kingdom	11	153 0.7×	119 0.8×	55 0.4×	31 0.5×	24 0.6×	31	307
Mariangela Zanghì Italy	7	234 1.0×	144 0.9×	211 1.6×	34 0.6×	40 1.0×	12	414
Peter Cheverton United Kingdom	11	313 1.4×	245 1.6×	137 1.0×	28 0.5×	18 0.4×	18	529
Keita Masuzawa Japan	10	239 1.0×	190 1.3×	285 2.2×	30 0.5×	19 0.5×	24	418

Countries citing papers authored by Eric Raymond

Since Specialization

Citations

This map shows the geographic impact of Eric Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Raymond more than expected).

Fields of papers citing papers by Eric Raymond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Raymond. The network helps show where Eric Raymond may publish in the future.

Co-authorship network of co-authors of Eric Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Raymond. A scholar is included among the top collaborators of Eric Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Raymond. Eric Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Nguyen‐Ngoc, Tu & Eric Raymond. (2015). Reinvention of chemotherapy. Current Opinion in Oncology. 27(3). 232–242. 8 indexed citations

2.

Malouf, Gabriel G., Chantal Dreyer, Nathalie Guedj, et al.. (2009). Facteurs pronostiques des cholangiocarcinomes : apport des données récentes de biologie moléculaire. Bulletin du Cancer. 96(4). 405–415. 1 indexed citations

3.

Cvitkovic, Esteban, Carmen Kahatt, Neil Senzer, et al.. (2004). Clinical activity of irofulven in hormone refractory prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 4766–4766. 1 indexed citations

4.

Cvitkovic, Esteban, Carmen Kahatt, Neil Senzer, et al.. (2004). Clinical activity of irofulven in hormone refractory prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 4766–4766. 2 indexed citations

5.

Faivre, Sandrine, Catherine Delbaldo, P. Pautier, et al.. (2004). Phase I study of ixabepilone given every other week in combination with irinotecan in patients with advanced malignancies. Journal of Clinical Oncology. 22(14_suppl). 2051–2051. 1 indexed citations

6.

Raymond, Eric, Sandrine Faivre, A M Coudray, Christophe Louvet, & Christian Gespach. (2001). [Preclinical studies of oxaliplatin in combination chemotherapy].. PubMed. 88 Spec No. S26–34. 10 indexed citations

7.

Raymond, Eric, Sandrine Faivre, & Jean Pierre Armand. (2000). Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy. Drugs. 60(Supplement 1). 15–23. 333 indexed citations

8.

Raymond, Eric, et al.. (1995). Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation. Cancer. 76(8). 1344–1351. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact